Biotech and Pharmaceuticals Pharmaceuticals

More

  • Eli Lilly Posts Loss Due to ImClone Purchase Thursday, 29 Jan 2009 | 9:43 AM ET
    lilly_hq.jpg

    Drugmaker Eli Lilly said Thursday it swung to a loss in the fourth quarter on charges from buying cancer-drug maker ImClone Systems.

  • Pfizer-Wyeth: The People & The WSJ Speak Wednesday, 28 Jan 2009 | 10:23 AM ET

    The editorial board of "The Wall Street Journal" weighs in today on the Pfizer-Wyeth deal. The opinion piece details all of the well-documented problems facing big pharma and—perhaps not surprisingly coming from the WSJ editorial page—blames Washington for many of them.

  • Investors Are Eating Pfizer's Lunch Tuesday, 27 Jan 2009 | 2:44 PM ET
    pfizer_hq.jpg

    Reporters could only listen to Pfizer's hastily-organized "Investor Luncheon," so I can't tell you how many people showed up or what the room looked like. But Chairman and CEO Jeff Kindler drew a pretty good picture at the start of his opening remarks.

  • Pfizer's Kindler Continues To Make His Case Tuesday, 27 Jan 2009 | 12:18 PM ET
    pfizer_wyet_ad.jpg

    This is the first paragraph/short story.

  • Stocks Eke Out Gain; Banks End Mixed Monday, 26 Jan 2009 | 5:12 PM ET

    Major indexes finished higher after a yo-yo session Monday, with banks ending mixed after several attempts at a rally.

  • Banks Lead Stock Rally, Boosted by Barclays Monday, 26 Jan 2009 | 12:53 PM ET

    Stocks rallied, led by banks, after a wobbly open Monday. The market also got a boost from a blockbuster pharma deal, which helped overshadow a gloomy outlook from Caterpillar and other earnings worries.

  • Pfizer & Wyeth

    As I've blogged before, it seems all of the major drug companies are falling all over each other to be the biggest, or at least the best "biopharma" firm in the world. But PFE and WYE are the first, as far as I know, to put it into a URL.

  • Stocks Get a Boost From Jump in Home Sales Monday, 26 Jan 2009 | 11:14 AM ET

    Stocks got a boost from a better-than-expected report on the housing market, which overshadowed Caterpillar's gloomy outlook and other earnings worries.

  • Futures Off Lows in Busy Earnings Day Monday, 26 Jan 2009 | 8:57 AM ET

    Stock index futures pointed to a dip at the opening, despite a mega-deal brewing in the pharmaceutical sector.

  • Making M&A Money in Big Pharma Friday, 23 Jan 2009 | 7:00 PM ET

    Who's next in the potential wave of consolidation set off by Pfizer and Wyeth? Cramer has an idea.

  • Game Plan: Four Hopeful Signs for Market Friday, 23 Jan 2009 | 6:52 PM ET

    Movement in a few key sectors could give stocks a much-needed boost.

  • The Politics And Science Of Geron Friday, 23 Jan 2009 | 2:57 PM ET
    Geron

    A few days into his term, President Obama appears to have begun to undo another Bush-era policy. He hasn't yet formally lifted the Bush-imposed ban on federal funding of new embryonic stem cell research, but Obama's Food and Drug Administration has already set the stage for it.

  • Analysts Explained Friday, 23 Jan 2009 | 2:25 PM ET

    Ever wonder how these people decide which stock's a buy and which is a sell? Now you know.

  • Forest Labs: Buy or Sell? Thursday, 22 Jan 2009 | 7:53 PM ET

    Depends on which analyst you believe. Find out who Cramer's siding with.

  • Pfizer Smells A Rat In Drug Counterfeiting Thursday, 22 Jan 2009 | 12:07 PM ET
    real_medicine_rat.jpg

    For years pharmaceutical companies and health authorities have been trying to crack down on counterfeit prescription drugs. But on a new United Kingdom website the world's biggest drug company, Pfizer, is apparently taking the fight against knockoffs to a whole nutha level.

  • Nissen: Plainspeaking In The Plain-Dealer Wednesday, 21 Jan 2009 | 12:31 PM ET
    Dr. Steven Nissen

    Dr. Steven Nissen, the cardiology chief at the Cleveland Clinic, reportedly remains on the shortlist to possibly become the next FDA Commissioner. Some analysts believe if Dr. Nissen gets the nod there could be a negative knee-jerk reaction in the big pharma sector stocks.

  • Buy Gold, Healthcare Stocks: Strategist Wednesday, 21 Jan 2009 | 8:34 AM ET

    1st paragraph of story should go here

  • J&J Drugs & Drug-Coated Stents Take A Big Hit Tuesday, 20 Jan 2009 | 12:44 PM ET
    johnson_johnson2_logo.jpg

    Dow component and giant healthcare company--you really can't lump it in with big pharma because it sells drugs, medical devices and consumer products--Johnson & Johnson reported earnings this morning.

  • Dendreon's JPMorgan Surprise Thursday, 15 Jan 2009 | 5:29 PM ET

    The JPMorgan Healthcare Conference typically frontloads the conference putting most, if not all, of the heavy hitters' presentations in the first couple of days of the four-day event. So, it's no surprise that a company the size of Dendreon was pulling up the rear. But that doesn't mean there wasn't any news.

  • Steve Jobs: Can His Case Help Propel Biopharma? Thursday, 15 Jan 2009 | 2:17 PM ET

    Even though it's one of the leading causes of cancer death in the U.S., pancreatic normally doesn't get much attention.